SAB Biotherapeutics
SABS | NASDAQ
$3.00
+$0.04 (+1.35%)
At close: Nov 16, 2026, 4:00 PM ET
$3.00
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:10 PM ET
SAB Biotherapeutics Institutional Ownership
Institutional ownership explainedInstitutional Ownership
Net OutflowTotal Institutions
92
Total Ownership
85.89%
Capital Flow
-$2.15M
Shares Change
-688.15K
Ownership Distribution
Institutions (85.89%)
Others (14.11%)
Institutional Sentiment
Overall: neutralEquity Sentiment & Activity
bullishNew Positions
31
Increased Positions
57
Reduced Positions
17
Closed Positions
21
New (31)
Increased (57)
Reduced (17)
Closed (21)
Options Sentiment & Activity
bearishPut/Call Ratio
1.390
Call Flow
163,000
Put Flow
226,500
Calls (42%)
Puts (58%)
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Caligan Partners LP | 9.99% -32.84% | 1.46% -28.01% | 7.97M 0.00% | 31.07M +1.83% | |
| Vivo Capital, LLC | 9.15% -57.07% | 2.60% -28.50% | 7.3M -36.08% | 28.47M -34.91% | |
| Perceptive Advisors LLC | 8.31% -30.80% | 0.39% -19.40% | 6.63M +3.04% | 25.85M +4.93% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove SABS